ABCs of secondary prevention of CHD: easier said than done.
Cohen
J D
JD
Department of Internal Medicine, St Louis University School of Medicine, MO 63104, USA. cohenjd@slu.edu
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D004032:Diet; D015444:Exercise; D006801:Humans; D009765:Obesity / Q000517:prevention & control; D010349:Patient Compliance; D016540:Smoking Cessation
D000319:Adrenergic beta-Antagonists; D000924:Anticholesteremic Agents; D001241:Aspirin